Machine learning for chronic kidney disease progression modelling: Leveraging data science to optimize patient management

Chronic Kidney Disease (CKD) is a progressive condition that affects millions globally, often leading to severe complications such as kidney failure and cardiovascular diseases. Early detection and personalized treatment plans are crucial for mitigating the progression of CKD and improving patient outcomes. Traditional methods of predicting CKD progression rely on clinical expertise and static risk assessment tools, which may not effectively leverage the wealth of patient data available today. Machine learning (ML) offers a data-driven approach to predict disease progression by analysing complex relationships within heterogeneous datasets, including laboratory results, demographic information, and comorbidities. ML models such as Random Forests, Gradient Boosting, and Support Vector Machines have demonstrated efficacy in predicting CKD progression. These algorithms excel in handling high-dimensional data and capturing nonlinear patterns, enabling accurate risk stratification and identification of key predictors. For example, ML models can analyse glomerular filtration rates (GFR), albumin levels, and other biomarkers to predict the likelihood of CKD progression or the onset of end-stage renal disease (ESRD). Additionally, these models facilitate personalized treatment recommendations by integrating patient-specific data, optimizing therapeutic interventions, and improving adherence to care protocols. However, challenges such as data quality, model interpretability, and ethical concerns regarding algorithmic bias must be addressed to ensure reliable and equitable deployment of ML solutions in clinical settings. This study explores the potential of ML in CKD progression modelling, highlighting case studies, model development, and validation techniques. It emphasizes the need for interdisciplinary collaboration to integrate ML-based tools into existing healthcare frameworks, ultimately enhancing CKD management and patient care.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-30
DOI
https://doi.org/10.5281/zenodo.15172573
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Machine learning for chronic kidney disease progression modelling: Leveraging data science to optimize patient management

Zenodo (CERN European Organization for Nuclear Research)
Chronic Kidney Disease and Diabetes
article

Machine learning for chronic kidney disease progression modelling: Leveraging data science to optimize patient management

article en

Abstract

Chronic Kidney Disease (CKD) is a progressive condition that affects millions globally, often leading to severe complications such as kidney failure and cardiovascular diseases. Early detection and personalized treatment plans are crucial for mitigating the progression of CKD and improving patient outcomes. Traditional methods of predicting CKD progression rely on clinical expertise and static risk assessment tools, which may not effectively leverage the wealth of patient data available today. Machine learning (ML) offers a data-driven approach to predict disease progression by analysing complex relationships within heterogeneous datasets, including laboratory results, demographic information, and comorbidities. ML models such as Random Forests, Gradient Boosting, and Support Vector Machines have demonstrated efficacy in predicting CKD progression. These algorithms excel in handling high-dimensional data and capturing nonlinear patterns, enabling accurate risk stratification and identification of key predictors. For example, ML models can analyse glomerular filtration rates (GFR), albumin levels, and other biomarkers to predict the likelihood of CKD progression or the onset of end-stage renal disease (ESRD). Additionally, these models facilitate personalized treatment recommendations by integrating patient-specific data, optimizing therapeutic interventions, and improving adherence to care protocols. However, challenges such as data quality, model interpretability, and ethical concerns regarding algorithmic bias must be addressed to ensure reliable and equitable deployment of ML solutions in clinical settings. This study explores the potential of ML in CKD progression modelling, highlighting case studies, model development, and validation techniques. It emphasizes the need for interdisciplinary collaboration to integrate ML-based tools into existing healthcare frameworks, ultimately enhancing CKD management and patient care.

Zenodo (CERN European Organization for Nuclear Research)
University of Maryland Global Campus (US)
Openalex Percentile: Top 50%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Machine learning for chronic kidney disease progression modelling: Leveraging data science to optimize patient management · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS